Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006536-04
Application #
6163276
Study Section
Special Emphasis Panel (M)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chen, Xiaohong; Gardner, Erin R; Figg, William D (2008) Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 865:153-8
Gardner, Erin R; Dahut, William; Figg, William D (2008) Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment. J Chromatogr B Analyt Technol Biomed Life Sci 862:213-8
Jain, Lokesh; Gardner, Erin R; Venitz, Jurgen et al. (2008) Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma. J Pharm Biomed Anal 46:362-7
Chen, Xiaohong; Gardner, Erin R; Gutierrez, Martin et al. (2007) Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 858:302-6
Bauer, K S; Lush, R M; Rudek, M A et al. (2000) A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva. Biomed Chromatogr 14:338-43
Rudek, M A; March, C L; Bauer Jr, K S et al. (2000) High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma. J Pharm Biomed Anal 22:1003-14
Buckner, J C; Malkin, M G; Reed, E et al. (1999) Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clin Proc 74:137-45
Park, B J; Brown, C K; Hu, Y et al. (1999) Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma. Hum Gene Ther 10:889-98
Cho, H K; Lush, R M; Bartlett, D L et al. (1999) Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis. J Clin Pharmacol 39:394-401
Figg, W D; Raje, S; Bauer, K S et al. (1999) Pharmacokinetics of thalidomide in an elderly prostate cancer population. J Pharm Sci 88:121-5

Showing the most recent 10 out of 11 publications